戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hatidylethanolamine, phosphatidylserine, and lysophosphatidylcholine.
2 mulate within phospholipid fractions such as lysophosphatidylcholine.
3 te lower levels of the "come-get-me" signal, lysophosphatidylcholine.
4  on the production of its catalytic product, lysophosphatidylcholine.
5 ighly selective generation of 2-arachidonoyl lysophosphatidylcholine.
6 ing in the production of a neutral lipid and lysophosphatidylcholine.
7 at McaP cleaves both phosphatidylcholine and lysophosphatidylcholine.
8 ing in the production of a neutral lipid and lysophosphatidylcholine.
9 poptosis by treatment with phosphocholine or lysophosphatidylcholine.
10 arachidonic acid, lysophosphatidic acid, and lysophosphatidylcholine.
11 pase activity toward the preferred substrate lysophosphatidylcholine.
12  Alcohol-induced hemifusion was inhibited by lysophosphatidylcholine.
13 nsion in the presence of meconium, serum, or lysophosphatidylcholine.
14 erol, free fatty acid, monoacylglycerol, and lysophosphatidylcholine.
15  (ATX), a secreted lysophospholipase D, from lysophosphatidylcholine.
16 xidized phospholipids with a high content in lysophosphatidylcholine.
17 rates are thought to be sphingomyelin and/or lysophosphatidylcholine.
18 nerates extracellular LPA from the precursor lysophosphatidylcholine.
19 was increased in lungs of mice that received lysophosphatidylcholine.
20 formation of early fusion intermediates with lysophosphatidylcholine.
21 for preparation of spectroscopically labeled lysophosphatidylcholines.
22 d extracts from D.42 plasma, or (d) purified lysophosphatidylcholines.
23 ofiling and regression analysis, we detected lysophosphatidylcholine 14:0, tryptophan, as well as pim
24                         We identified plasma lysophosphatidylcholine 16:0, lysophosphatidylcholine 17
25 rom eight identifiable metabolites including lysophosphatidylcholine (16:0) and tyrosine.
26 , diacyl phosphatidylcholines 36:4 and 38:4, lysophosphatidylcholine 17:0, and hydroxy-sphingomyelin
27 ntified plasma lysophosphatidylcholine 16:0, lysophosphatidylcholine 17:0, and lysophosphatidylcholin
28 line 16:0, lysophosphatidylcholine 17:0, and lysophosphatidylcholine 18:0 as significant metabolites
29  stimulated the production of 2-arachidonoyl-lysophosphatidylcholine (2-AA-LPC) from 1-palmitoyl-2-[(
30                                       2-Acyl-lysophosphatidylcholine (2-acyl LPC), fatty acids ethyl
31 d on 1) the temporal inhibition of fusion by lysophosphatidylcholine, 2) rapid dissociation of the HA
32                                              Lysophosphatidylcholine (20:4) and cholic acid also cont
33 n of the resistance-inducing lipid mediator, lysophosphatidylcholine(24:1).
34                         Liposomes containing lysophosphatidylcholine (30 mol %) or treated with benzy
35 d coronary sinus for measurement of Lp-PLA2, lysophosphatidylcholine (a product of Lp-PLA2), and C-re
36                                              Lysophosphatidylcholine, a component of both oxidatively
37                                  Infusion of lysophosphatidylcholine, a component of oxidized low den
38 mmatory consequences have been described for lysophosphatidylcholine, a lipid product of cellular inj
39 ogical role of this system is to internalize lysophosphatidylcholine, a signalling lipid involved in
40 rophages upon exposure to apoptotic cells or lysophosphatidylcholine, a specific phospholipid that is
41                                    Levels of lysophosphatidylcholine, a toxic metabolite of phospholi
42 l insulin secretion and a role in generating lysophosphatidylcholine acceptors for arachidonic acid i
43 ipid reacylation by a novel Golgi-associated lysophosphatidylcholine acyltransferase (LPAT) induces t
44 es to LPS, was found to selectively activate lysophosphatidylcholine acyltransferase (LPCAT) (P < 0.0
45 PC) and sphingomyelin levels due to elevated lysophosphatidylcholine acyltransferase (LPCAT) and sphi
46  catalyzed by the reverse action of acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) can tran
47                                     Acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) enzymes
48                                              Lysophosphatidylcholine acyltransferase (LPCAT) is an ev
49 ), lysophospholipid acyltransferase (LPEAT), lysophosphatidylcholine acyltransferase (LPCAT), and lys
50         The reacylation step is catalyzed by lysophosphatidylcholine acyltransferase (LPCAT), and we
51 enzyme in the Lands' cycle is fatty acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT), which u
52                          The enzyme acyl-CoA:lysophosphatidylcholine acyltransferase (Lpcat1) is a cr
53  mouse enzyme with characteristics of a lung lysophosphatidylcholine acyltransferase (LPCAT1) that we
54                                     Acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1) is a
55                                      Hepatic lysophosphatidylcholine acyltransferase 3 (LPCAT3) has c
56 show that the phospholipid remodeling enzyme lysophosphatidylcholine acyltransferase 3 (Lpcat3) is a
57                                              Lysophosphatidylcholine acyltransferase 3 (Lpcat3) is in
58 es and proteins involved in LPC degradation (lysophosphatidylcholine acyltransferase [Lpcat] 1-4), ba
59 ophospholipids, and overexpression increased lysophosphatidylcholine acyltransferase activity 7-fold.
60 ivum) leaf protoplasts indicated that 30% of lysophosphatidylcholine acyltransferase activity colocal
61 n of the remodeling enzyme, LPCAT1 (acyl-CoA:lysophosphatidylcholine acyltransferase) in epithelia de
62 hift, leading to premature truncation of the lysophosphatidylcholine acyltransferase-1 (LPCAT1) prote
63                  SP-A, as well as the enzyme lysophosphatidylcholine acyltransferase-1 (LPCAT1), requ
64 , we demonstrate that two genes encoding the lysophosphatidylcholine acyltransferases LPCAT1 and LPCA
65                                          The lysophosphatidylcholine analogue edelfosine is a potent
66 nal tunability by the anionic phospholipids, lysophosphatidylcholine and cholesterol.
67 duced lipid mixing was reversibly blocked by lysophosphatidylcholine and low temperature, 4 degrees C
68                                              Lysophosphatidylcholine and lyso-platelet-activating fac
69                               MBOAT5 prefers lysophosphatidylcholine and lyso-PS to incorporate linol
70                          We also report that lysophosphatidylcholine and lysophosphatidic acid levels
71            Ablation of pPLAIIalpha decreased lysophosphatidylcholine and lysophosphatidylethanolamine
72 high levels of amino acids but low levels of lysophosphatidylcholine and lysophosphatidylethanolamine
73 ed by agents that thin the membrane (L-alpha-lysophosphatidylcholine and octyl-beta-D-glucopyranoside
74 ities of the two pro-inflammatory mediators, lysophosphatidylcholine and oxidized nonesterified fatty
75 aflet lipid with phospholipase A2 to produce lysophosphatidylcholine and palmitate which were then re
76 inhibition of fusion by inverted cone-shaped lysophosphatidylcholine and promotion by cone-shaped ole
77 f systemin blocked both the release of (14)C-lysophosphatidylcholine and the accumulation of defense
78 de decreases both the steady-state levels of lysophosphatidylcholine and the capacity of the cell to
79 nd to phosphatidyl lipids, but did recognize lysophosphatidylcholine and the phosphorylcholine head g
80 ells in the presence of the fusion inhibitor lysophosphatidylcholine and then removed the inhibitor t
81 fer from water to self-assembled micelles of lysophosphatidylcholines and diacyl phosphatidylcholines
82 tigotes occurred to phosphatidylcholines and lysophosphatidylcholines and results indicate that the K
83  the plasma membrane, resulting in a peak of lysophosphatidylcholine, and (2) a subsequent, transient
84 nhibition in the adenosine, PG/lipoxygenase, lysophosphatidylcholine, and sphingosine-1-phosphate pat
85 support a novel transport mechanism by which lysophosphatidylcholines are "flipped" within the transp
86 yso-PE and lysophosphatidylglycerol, but not lysophosphatidylcholine, are taken up by LplT for reacyl
87 ments a V. cholerae VolA mutant in growth on lysophosphatidylcholine as the sole carbon source and in
88 lated splenic macrophages identifies several lysophosphatidylcholines as the resistance-inducing mole
89 vity and the signaling pathway through which lysophosphatidylcholine augments endothelial nitric-oxid
90 ythmogenic toxins (eg, ouabain, high Ca(2+), lysophosphatidylcholine, beta-adrenergic agonist, acylca
91 phatidylcholine, lysophosphatidylserine, and lysophosphatidylcholine but lacked appreciable acylating
92                                    Exogenous lysophosphatidylcholine but not arachidonic acid mimicke
93 human eosinophils degranulate in response to lysophosphatidylcholine, but not phosphatidylcholine, ly
94 s C34:3, C40:6, C42:5, C44:4, and C44:5; and lysophosphatidylcholine C18:2 with decreased risk.
95                                              Lysophosphatidylcholine (C24:0) injection in mice led to
96 l activation in human ALD (10 autopsies) and lysophosphatidylcholine (C24:0) injection into the parie
97                        ATX and its substrate lysophosphatidylcholine can be detected in the uterine e
98                       Acylation of exogenous lysophosphatidylcholine circumvented the requirement for
99 reperfusion caused a significant increase in lysophosphatidylcholine concentration compared with cont
100  urocortin, the ischemia-induced increase in lysophosphatidylcholine concentration was significantly
101                                  Unsaturated lysophosphatidylcholine containing docosahexaenoic acid
102 lesion Lp-PLA(2) activity and reduced lesion lysophosphatidylcholine content.
103 n reactions of a docosahexaenoate ester of 2-lysophosphatidylcholine (DHA-PC) was also demonstrated.
104  to arachidonic acid, lysophosphatidic acid, lysophosphatidylcholine, diacylglycerol, monoacylglycero
105    We also elicited SMase activity by adding lysophosphatidylcholine externally or by generating it w
106           VolA functions to cleave exogenous lysophosphatidylcholine, freeing the fatty acid moiety f
107                             Since removal of lysophosphatidylcholine from Ca2+-treated CV is known to
108  potently releases arachidonic acid (AA) and lysophosphatidylcholine from mammalian cell membranes.
109  +/- 0.1 to 2.1 +/- 0.3 nmol/mg of protein), lysophosphatidylcholine (from 0.3 +/- 0.1 to 0.6 +/- 0.1
110 tes, respectively) significantly faster than lysophosphatidylcholine (&gt;60 and 37.8 minutes, respectiv
111                                              Lysophosphatidylcholine has been shown to enhance neutro
112 salt-independent hydrolytic activity against lysophosphatidylcholine, having 6.5- and 2-fold higher k
113 -9-hydroxy-13-oxotridec-11-enoate ester of 2-lysophosphatidylcholine (HOT-PC) was devised to facilita
114 tributed to the lower levels of ceramide and lysophosphatidylcholine in CEL-expressing cells than in
115 TAG and the accumulation of small amounts of lysophosphatidylcholine in developing seeds revealed by
116 mplexes in vitro and increased the levels of lysophosphatidylcholine in Golgi membranes.
117 alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine in human atherosclerotic lesions
118 ty, as measured by the accumulation of (14)C-lysophosphatidylcholine in leaves of tomato plants, incr
119 xins cleave the substrates sphingomyelin and lysophosphatidylcholine in mammalian tissues, releasing
120 is because of its hydrolysis of ceramide and lysophosphatidylcholine in promoting cholesterol esterif
121 hallenge altered the concentration of plasma lysophosphatidylcholines in an oil treatment-dependent m
122 r was associated with lower cord-blood total lysophosphatidylcholines in index and control children.
123                                    In vitro, lysophosphatidylcholine increased the expression of alka
124 hepatocytes and Huh7 cells with palmitate or lysophosphatidylcholine increased their release of EVs,
125 isruption of paranodal myelin (by stretch or lysophosphatidylcholine) increased the stimulation-induc
126                          We then showed that lysophosphatidylcholine-induced mineralization involved
127 infectivity) and the fusion-inhibitory agent lysophosphatidylcholine inhibit the formation of the >15
128                   Autotaxin (ATX) transforms lysophosphatidylcholine into lysophosphatidic acid.
129 of lysophospholipids and PUFAs are such that lysophosphatidylcholine is able to modulate TRPM8 in the
130 s not support the stalk (e.g., as it is when lysophosphatidylcholine is added), hemifusion is inhibit
131  of known specificities demostrated that the lysophosphatidylcholine is generated by a PLA with speci
132           A new stereoselective synthesis of lysophosphatidylcholines is reported.
133                       The diacyl metabolite, lysophosphatidylcholine, is arrhythmogenic, but the effe
134                            Exposure of [(3)H]lysophosphatidylcholine-labeled neutrophils to LKT cause
135                                        (14)C-lysophosphatidylcholine levels did not increase in respo
136 hroughput screen of ATX inhibition using the lysophosphatidylcholine-like substrate fluorogenic subst
137 n the cecum, as well as elevated atherogenic lysophosphatidylcholine (LPC 18:1) and lysophosphatidic
138 /-) HDL had a 4-fold increase in PC, whereas lysophosphatidylcholine (LPC) (125-fold), sphingomyelin
139 dministration of DHA to normal adult mice as lysophosphatidylcholine (LPC) (40 mg DHA/kg) for 30 days
140  A housekeeping role for iPLA2 in generating lysophosphatidylcholine (LPC) acceptors for arachidonic
141              We examined both the effects of lysophosphatidylcholine (LPC) and hydrogen peroxide (H(2
142 s in serum palmitoyl-, stearoyl-, and oleoyl-lysophosphatidylcholine (LPC) and marked increases in ta
143 exposure in mice resulted in decreased serum lysophosphatidylcholine (LPC) and sphingomyelin levels d
144        Sphingosylphosphorylcholine (SPC) and lysophosphatidylcholine (LPC) are bioactive lipid molecu
145 n assay, we found that phospholipids such as lysophosphatidylcholine (LPC) can stimulate the sulfatid
146 ots and seeds and large increases in LPE and lysophosphatidylcholine (LPC) contents in leaves.
147  dose-dependent manner, while treatment with lysophosphatidylcholine (LPC) enhanced the expression of
148              Our recent study indicates that lysophosphatidylcholine (LPC) enhances Sp1 binding and S
149 d the presence of monoacylglycerol (MAG) and lysophosphatidylcholine (LPC) hydrolytic activities, ind
150 actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and sys
151                                Generation of lysophosphatidylcholine (LPC) in such systems cannot be
152 exhibited excellent remyelinating effects on lysophosphatidylcholine (LPC) induced demyelination in a
153 f asymmetrically incorporating single-tailed lysophosphatidylcholine (LPC) into a membrane bilayer us
154 mbrane merger was prevented by incorporating lysophosphatidylcholine (LPC) into cell membranes at the
155 secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine (LPC) into lysophosphatidic acid
156  G2A, a G protein-coupled receptor for which lysophosphatidylcholine (LPC) is a high affinity ligand,
157                                              Lysophosphatidylcholine (LPC) is a naturally occurring i
158                                              Lysophosphatidylcholine (LPC) is an oxidized phospholipi
159 riments show that the soluble lipid mediator lysophosphatidylcholine (LPC) is released by p25 overexp
160  application of micromolar concentrations of lysophosphatidylcholine (LPC) led to an increase of the
161  a housekeeping enzyme that regulates cell 2-lysophosphatidylcholine (LPC) levels and arachidonate in
162                                     Finally, lysophosphatidylcholine (LPC) levels in the PFC were fou
163                                      LPA and lysophosphatidylcholine (LPC) levels in the tumor microe
164  a housekeeping enzyme that regulates cell 2-lysophosphatidylcholine (LPC) levels, rates of arachidon
165 r/water interface, we measured the effect of lysophosphatidylcholine (LPC) on adsorption.
166 activity (PLA2) of Prdx6; addition of either lysophosphatidylcholine (LPC) or lysophosphatidic acid (
167             Here, we describe our studies of lysophosphatidylcholine (LPC) presentation by human CD1d
168 terization of these ligands revealed several lysophosphatidylcholine (LPC) species.
169 sophosphatidylglycerol (LPG) or zwitterionic lysophosphatidylcholine (LPC) stimulate aggregation, LPG
170 Mfsd2a is a newly described sodium-dependent lysophosphatidylcholine (LPC) symporter expressed at the
171  ectoenzyme that catalyzes the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (
172 ce chemotaxis through its ability to convert lysophosphatidylcholine (LPC) to lysophosphatidic acid (
173 ted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosp
174 he circulation is through a sodium-dependent lysophosphatidylcholine (LPC) transporter (MFSD2A), expr
175 ce expression was enhanced and stabilized by lysophosphatidylcholine (LPC) treatment.
176 ipids, we separately examined the effects of lysophosphatidylcholine (LPC) upon microglia.
177 ple tumor types, autotaxin produces LPA from lysophosphatidylcholine (LPC) via lysophospholipase D ac
178             Previous studies have shown that lysophosphatidylcholine (LPC), a bioactive lipid associa
179  Oxidized low density lipoprotein (OxLDL) or lysophosphatidylcholine (LPC), a major component of OxLD
180                In this study, we reveal that lysophosphatidylcholine (LPC), a molecule associated wit
181 her Lp-PLA2 and its major enzymatic product, lysophosphatidylcholine (LPC), are involved in blood-ret
182 es as opposed to vesicles containing L-alpha-lysophosphatidylcholine (LPC), as observed using atomic
183 tion was blocked by the hemifusion inhibitor lysophosphatidylcholine (LPC), but not if a complementar
184  We report here that increased production of lysophosphatidylcholine (LPC), catalyzed by the activati
185 large amounts of AA and the lysophospholipid lysophosphatidylcholine (LPC), from membrane preparation
186 ed were albumin, hemoglobin, C16:0 and C18:1 lysophosphatidylcholine (LPC), oleic acid (OA), palmitol
187 adherent HA-cell at different time points by lysophosphatidylcholine (LPC), so that only the cell pai
188       Amylose forms inclusion complexes with lysophosphatidylcholine (LPC), that decrease the suscept
189 idermal keratinocytes and we have shown that lysophosphatidylcholine (LPC), the main lysophospholipid
190                 Abundance of proinflammatory lysophosphatidylcholine (LPC), which was detectable in b
191 the selective accumulation of 2-arachidonoyl lysophosphatidylcholine (LPC), which was not metabolized
192 v administration, although more radiolabeled lysophosphatidylcholine (LPC)-DHA enters the brain than
193 t carotid arteries to compare the effects on lysophosphatidylcholine (LPC)-induced endothelial dysfun
194  acute focal neuroinflammation in the brain, lysophosphatidylcholine (LPC)-induced focal demyelinatio
195 inal cord dorsal column by microinjection of lysophosphatidylcholine (LPC).
196 ctive lipid lysophosphatidic acid (LPA) from lysophosphatidylcholine (LPC).
197 established role in liver disease, including lysophosphatidylcholine (LPC).
198 receptor for the bioactive lysophospholipid, lysophosphatidylcholine (LPC).
199 inity receptor for SPC with low affinity for lysophosphatidylcholine (LPC).
200 nd Huh7 cells were treated with palmitate or lysophosphatidylcholine (LPC).
201 is also specific for the lysolipids LGL1 and lysophosphatidylcholine (LPC).
202  as well as other fatty acids in the form of lysophosphatidylcholine (LPC).
203                     Plasma levels of several lysophosphatidylcholines (LPCs), including 18:1- and 18:
204 ich results in production of chemoprotective lysophosphatidylcholines (LPCs).
205  positively curved lipids (ganglioside, GM1; lysophosphatidylcholine, LPCs) and negatively curved lip
206     Medium from endothelial cells exposed to lysophosphatidylcholine (lyso-ECCM), a product of LpL li
207  the production of arachidonic acid (AA) and lysophosphatidylcholine (Lyso-PC) by activating multiple
208                           We have shown that lysophosphatidylcholine (lyso-PC) increases endothelial
209                                              Lysophosphatidylcholine (lyso-PC) is a major component o
210                                              Lysophosphatidylcholine (lyso-PC), a natural lipid gener
211 inoleyl hydroperoxide (LAox or 13-HPODE) and lysophosphatidylcholine (lyso-PC), abundant components o
212  plasma membrane, liberating fatty acids and lysophosphatidylcholine (lyso-PC), whereas cPLA(2) acted
213                                              Lysophosphatidylcholine, lyso-platelet-activating factor
214 y phosphatidylcholine (PC) remodeling, and a lysophosphatidylcholine (lysoPC) acyltransferase is thou
215      We report the characterization of three lysophosphatidylcholine (lysoPC) acyltransferases (LPCAT
216 line acyltransferase (LPCAT), which utilizes lysophosphatidylcholine (LysoPC) and fatty acyl-CoA to p
217  implicated PA, phosphatidylcholine (PC) and lysophosphatidylcholine (LysoPC) as potential SOBER1 sub
218  significantly elevated erythrocyte membrane lysophosphatidylcholine (LysoPC) content and circulating
219    Here, we show that the host-derived lipid lysophosphatidylcholine (LysoPC) controls P. falciparum
220 nd colleagues describes a host-derived lipid lysophosphatidylcholine (LysoPC) that regulates sexual c
221                                      Because lysophosphatidylcholine (lysoPC), a major lipid constitu
222          Lipid oxidation products, including lysophosphatidylcholine (lysoPC), activate canonical tra
223 hen endothelial cells (ECs) are incubated in lysophosphatidylcholine (lysoPC), rapid translocation of
224     Progressively lower levels of long-chain lysophosphatidylcholines (lysoPC a C18:2, lysoPC a C20:3
225                                          Two lysophosphatidylcholines, LysoPC (16:0) and LysoPC (18:0
226           PCh in EPCR could be exchanged for lysophosphatidylcholine (lysoPCh) and platelet activatin
227 and triacylglycerides, sphingomyelins (SMs), lysophosphatidylcholines (LysoPCs), and esterified stero
228                              Certain lipids (lysophosphatidylcholine, lysophosphatidic acid, and pros
229 r lysophospholipids as substrates, including lysophosphatidylcholine, lysophosphatidylethanolamine, a
230 dding yeast P4-ATPases Dnf1 and Dnf2 include lysophosphatidylcholine, lysophosphatidylethanolamine, d
231 or a variety of lysophospholipids, including lysophosphatidylcholine, lysophosphatidylethanolamine, l
232                    Lysophospholipids (LPLs) (lysophosphatidylcholine, lysophosphatidylinositol, and l
233 olamine, lysophosphatidylglycerol, 1-O-alkyl-lysophosphatidylcholine, lysophosphatidylserine, and lys
234 duct shows lysophospholipase activity toward lysophosphatidylcholine, lysophosphatidylserine, and lys
235                                         Four lysophosphatidylcholines (m/z 490-540) accounted for abo
236 ent in wild-type mice), a 4-fold increase in lysophosphatidylcholine mass in ischemic zones (4.9 nmol
237 ter time points (3 to 24 h), suggesting that lysophosphatidylcholine may, at least in part but not so
238 e production of a novel group of unsaturated lysophosphatidylcholine molecular species and chlorinate
239 lasmalogen cooxidation products, unsaturated lysophosphatidylcholine molecular species containing lin
240                                  Unsaturated lysophosphatidylcholine molecular species elicited cycli
241 ery endothelial cells to plasmalogen-derived lysophosphatidylcholine molecular species produced marke
242 rated that a novel population of unsaturated lysophosphatidylcholine molecular species was produced b
243 l activated oleosin phosphorylation, whereas lysophosphatidylcholine, oleic acid, and Ca(2+) inhibite
244 y, this process was dependent on exposure of lysophosphatidylcholine on activated cell membranes, whi
245    Recent data support an indirect effect of lysophosphatidylcholine on G2A rather than direct ligand
246 hat predict a plausible recognition site for lysophosphatidylcholine only in EcNHX1.
247 actone, reduces the cytotoxicity produced by lysophosphatidylcholine or ischemia/reperfusion.
248 ation was increased by exposure to exogenous lysophosphatidylcholine or lysophosphatidylethanolamine.
249 herosclerotic plaque, including CD40 ligand, lysophosphatidylcholine, or cholesterol crystals, could
250 ere incubated with palmitate, its metabolite lysophosphatidylcholine, or diluent (control).
251 elin, lysophingomyelin, phosphatidylcholine, lysophosphatidylcholine, or phosphatidic acid among the
252 reas in vivo remyelination is accelerated in lysophosphatidylcholine- or cuprizone-induced demyelinat
253 ividual species of cholesterol esters (CEs), lysophosphatidylcholines, phosphatidylcholines, phosphat
254 ipid compartment in the plasma membrane with lysophosphatidylcholine, previously shown to decrease ch
255 eukin 6 (IL-6) and lipid (neutral lipids and lysophosphatidylcholines) priming activity (P <.05).
256                    Chemical acylation of the lysophosphatidylcholine produced by wounding, systemin,
257                    Both arachidonic acid and lysophosphatidylcholine, products of iPLA2beta action, i
258 f this model, the inverted cone-shaped lipid lysophosphatidylcholine rescues secretion from SNARE mut
259 ted diacylglycerols, phosphatidic acids, and lysophosphatidylcholines, respectively.
260                                    Exogenous lysophosphatidylcholine restores LPS-stimulated secretio
261  Treatment with increasing concentrations of lysophosphatidylcholine resulted in a dose-dependent red
262                                              Lysophosphatidylcholine selectively activated p42/p44 mi
263 ilis QST713 as well as digitonin, CHAPS, and lysophosphatidylcholine solubilize membranes without sub
264 common endogenous compound classes (e.g., 51 lysophosphatidylcholines spectra) and were then used to
265 complexes formed with diverse lipids such as lysophosphatidylcholine, sulfatide, or mannosyl-phosopho
266               Neither CCT overexpression nor lysophosphatidylcholine supplementation allowed the HeLa
267 ylcholine, and heightened CCT expression and lysophosphatidylcholine supplementation were equally eff
268 ses phosphatidylcholine as substrate to form lysophosphatidylcholine that has the potential to disrup
269  A2 activity, with the subsequent release of lysophosphatidylcholine that influences macrophage chole
270 se-induced adaptation, we identified various lysophosphatidylcholines that might function as surrogat
271                 Local coronary production of lysophosphatidylcholine, the active product of Lp-PLA2,
272                                The effect of lysophosphatidylcholine, the product of Lp-PLA2 activity
273 ge of arachidonate and linoleate esters of 2-lysophosphatidylcholine, the two most abundant polyunsat
274 endent proton fluxes that were stimulated by lysophosphatidylcholine, thus giving rise to a net efflu
275 duced both by micropipette aspiration and by lysophosphatidylcholine to become irreversible.
276 that facilitates the conversion of palmitoyl-lysophosphatidylcholine to dipalmitoylphosphatidylcholin
277 lypeptide hormone systemin also caused (14)C-lysophosphatidylcholine to increase to levels similar to
278 pholipase D that catalyzes the conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA).
279 n (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA).
280 d for preparing cell-free nerve grafts using lysophosphatidylcholine to remove cells, axons, and myel
281    Inhibition was largely overcome by adding lysophosphatidylcholine to the medium at concentrations
282 recently characterized as a sodium-dependent lysophosphatidylcholine transporter expressed at the blo
283 -1 inhibition improves the tube formation of lysophosphatidylcholine-treated HAECs.
284 ses caspase-1 activation in HAECs induced by lysophosphatidylcholine treatment.
285              We previously demonstrated that lysophosphatidylcholine up-regulated endothelial nitric-
286 ine, the headgroup of both sphingomyelin and lysophosphatidylcholine, versus ethanolamine.
287                            Net production of lysophosphatidylcholine was higher in patients compared
288 thesis of CysLTs in response to sPLA(2)-X or lysophosphatidylcholine was inhibited by p38 or JNK inhi
289              Plasma level of the atherogenic lysophosphatidylcholine was lower in the CEL transgenic
290 bit aortic endothelial cells stimulated with lysophosphatidylcholine, we observed an increase in VCAM
291 -sn-glycero-3-phosphocholine, and of various lysophosphatidylcholines were also significantly elevate
292                                              Lysophosphatidylcholines were associated with aspartate
293 oduced when lipid extracts of D.42 plasma or lysophosphatidylcholines were perfused into LPS-pretreat
294 s, phosphatidylcholines, sphingomyelins, and lysophosphatidylcholines were unchanged.
295 layer bending in a manner similar to that of lysophosphatidylcholine, were here found to promote hemi
296  and of 18:1 in phosphatidylethanolamine and lysophosphatidylcholine, whereas concomitant decreases w
297        However, disruption is not blocked by lysophosphatidylcholine, which transiently arrests a lat
298  metabolites, gamma-glutamyl dipeptides, and lysophosphatidylcholines, which are considered to be inv
299 ns were semi-synthesized by acylation of C20-lysophosphatidylcholine with unsaturated C20 fatty acids
300 ion that adding the positive curvature agent lysophosphatidylcholine would synergistically lower line

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top